Xiang-Yang Ye,Christian L. Morales,Mendi A. Higgins,Eric Mull
申请号：
US16347831
公开号：
US10745384B2
申请日:
2017.11.07
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides compounds of Formula (Ia) or (Ib): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds are antagonists to αV-containing integrins. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with dysregulation of αV-containing integrins, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.
